Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

CorrigendumHematology Free access | 10.1172/JCI34239C1

Loss of PIP5KIγ, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes

Yanfeng Wang, Rustem I. Litvinov, Xinsheng Chen, Tami L. Bach, Lurong Lian, Brian G. Petrich, Susan J. Monkley, Yasunori Kanaho, David R. Critchley, Takehiko Sasaki, Morris J. Birnbaum, John W. Weisel, John Hartwig, and Charles S. Abrams

Find articles by Wang, Y. in: JCI | PubMed | Google Scholar

Find articles by Litvinov, R. in: JCI | PubMed | Google Scholar

Find articles by Chen, X. in: JCI | PubMed | Google Scholar

Find articles by Bach, T. in: JCI | PubMed | Google Scholar

Find articles by Lian, L. in: JCI | PubMed | Google Scholar

Find articles by Petrich, B. in: JCI | PubMed | Google Scholar

Find articles by Monkley, S. in: JCI | PubMed | Google Scholar

Find articles by Kanaho, Y. in: JCI | PubMed | Google Scholar

Find articles by Critchley, D. in: JCI | PubMed | Google Scholar

Find articles by Sasaki, T. in: JCI | PubMed | Google Scholar

Find articles by Birnbaum, M. in: JCI | PubMed | Google Scholar

Find articles by Weisel, J. in: JCI | PubMed | Google Scholar

Find articles by Hartwig, J. in: JCI | PubMed | Google Scholar

Find articles by Abrams, C. in: JCI | PubMed | Google Scholar

Published January 10, 2008 - More info

Published in Volume 119, Issue 2 on February 2, 2009
J Clin Invest. 2009;119(2):421–421. https://doi.org/10.1172/JCI34239C1.
© 2008 The American Society for Clinical Investigation
Published January 10, 2008 - Version history
View PDF

Related article:

Loss of PIP5KIγ, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes
Yanfeng Wang, … , John Hartwig, Charles S. Abrams
Yanfeng Wang, … , John Hartwig, Charles S. Abrams
Research Article Hematology

Loss of PIP5KIγ, unlike other PIP5KI isoforms, impairs the integrity of the membrane cytoskeleton in murine megakaryocytes

  • Text
  • PDF
Abstract

Phosphatidylinositol-4,5-bisphosphate (PIP2) is an abundant phospholipid that contributes to second messenger formation and has also been shown to contribute to the regulation of cytoskeletal dynamics in all eukaryotic cells. Although the α, β, and γ isoforms of phosphatidylinositol-4-phosphate-5-kinase I (PIP5KI) all synthesize PIP2, mammalian cells usually contain more than one PIP5KI isoform. This raises the question of whether different isoforms of PIP5KI fulfill different functions. Given the speculated role of PIP2 in platelet and megakaryocyte actin dynamics, we analyzed murine megakaryocytes lacking individual PIP5KI isoforms. PIP5KIγ–/– megakaryocytes exhibited plasma membrane blebbing accompanied by a decreased association of the membrane with the cytoskeleton. This membrane defect was rescued by adding back wild-type PIP5KIγ, but not by adding a catalytically inactive mutant or a splice variant lacking the talin-binding motif. Notably, both PIP5KIβ- and PIP5KIγ–/– cells had impaired PIP2 synthesis. However, PIP5KIβ-null cells lacked the membrane-cytoskeleton defect. Furthermore, overexpressing PIP5KIβ in PIP5KIγ–/– cells failed to revert this defect. Megakaryocytes lacking the PIP5KIγ-binding partner, talin1, mimicked the membrane-cytoskeleton defect phenotype seen in PIP5KIγ–/– cells. These findings demonstrate a unique role for PIP5KIγ in the anchoring of the cell membrane to the cytoskeleton in megakaryocytes, probably through a pathway involving talin. These observations further demonstrate that individual PIP5KI isoforms fulfill distinct functions within cells.

Authors

Yanfeng Wang, Rustem I. Litvinov, Xinsheng Chen, Tami L. Bach, Lurong Lian, Brian G. Petrich, Susan J. Monkley, David R. Critchley, Takehiko Sasaki, Morris J. Birnbaum, John W. Weisel, John Hartwig, Charles S. Abrams

×

Original citation: J. Clin. Invest.118:812–819 (2002). doi:10.1172/JCI34239.

Citation for this corrigendum: J. Clin. Invest.119:421 (2009). doi:10.1172/JCI34239C1.

During the preparation of the manuscript, Yasunori Kanaho’s name was inadvertently omitted from the author list. The correct author list appears above, and Kanaho’s affiliation information appears below.

Department of Physiological Chemistry, Graduate School of Comprehensive Human Sciences and Institute of Basic Medical Sciences, University of Tsukuba, Tsukuba, Japan.

The authors regret the error.

Version history
  • Version 1 (January 10, 2008): No description
  • Version 2 (February 2, 2009): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts